Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

134.73 +23.54 (+21.17%)
Official Closing Price Updated: 7:00 PM EST, Feb 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers ↗
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and... 
Via Benzinga
News headline image
6 Analysts Assess DaVita: What You Need To Know ↗
 
Via Benzinga
News headline image
Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal ↗
Tandem Diabetes stock surged above a profit-taking zone on Friday, but DaVita reversed course and tumbled at the open. 
Via Investor's Business Daily
News headline image
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy? ↗
Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses. 
Via InvestorPlace
News headline image
DaVita (DVA) Q1 2024 Earnings Call Transcript ↗
DVA earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
DaVita Inc. (NYSE: DVA) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
News headline image
DaVita Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗
 
Via Benzinga
News headline image
Why DaVita Stock Popped Today ↗
The dialysis services company handily beat expectations with its latest quarter. 
Via The Motley Fool
News headline image
DaVita: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q1 2024 ↗
DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026 ↗
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology. 
Via InvestorPlace
News headline image
Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now? ↗
These high-flying Buffett stocks could be attractive to different kinds of investors. 
Via The Motley Fool
News headline image
Ford, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses ↗
Ford, United Airlines and megacap AI stock Nvidia were big-cap winners. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
News headline image
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher ↗
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use. 
Via Investor's Business Daily
News headline image
The Best Warren Buffett Stocks to Buy With $300 Right Now ↗
Even with $300, many Buffett investments are within reach of the average investor. 
Via The Motley Fool
News headline image
3 Soaring, Highly-Ranked Value Stocks To Buy In April ↗
The stock market bounced back on Wednesday and looked strong through morning trading Thursday until sellers showed up. 
Via Talk Markets
News headline image
3 High-Dividend ETFs That Could Be Smart Investments Right Now ↗
These are three great ways to get income in your portfolio without the hard work of choosing stocks and bonds on your own. 
Via The Motley Fool
Topics Bonds ETFs
News headline image
Warren Buffett's Berkshire Hathaway Owns Over 25% of These 4 Companies (Hint: Apple Isn't One of Them) ↗
Berkshire even lists one of these companies as a subsidiary. 
Via The Motley Fool
News headline image
3 No-Brainer Warren Buffett Stocks to Buy Right Now ↗
Strong brands and market presence make these three companies attractive investments. 
Via The Motley Fool
News headline image
Why Are Dialysis Provider Stocks Trading Higher On Tuesday? ↗
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks 
Via Benzinga
News headline image
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
News headline image
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News ↗
Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease. 
Via Investor's Business Daily
News headline image
3 Cheap Stocks to Buy Now for Fast Gains ↗
Dive into the world of investing with cheap stocks DaVita, Altria, and StoneCo as they show potential growth. 
Via InvestorPlace
News headline image
Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details ↗
Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024. 
Via Benzinga
News headline image
3 Top-Rated Stocks To Buy After Comfortably Surpassing Earnings Expectations ↗
This week’s earnings lineup has featured several top-rated stocks that have added to this optimistic growth narrative and here are a few to consider 
Via Talk Markets
News headline image
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday. 
Via Benzinga
Topics Stocks
News headline image
DaVita (DVA) Q4 2023 Earnings Call Transcript ↗
DVA earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
Time To Buy These High Growth Stocks As Earnings Approach ↗
This week’s earnings lineup will be highlighted by several growth stocks with none standing out more than Airbnb and DaVita 
Via Talk Markets
News headline image
Earnings Scheduled For February 13, 2024 ↗
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million. 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.